{"id":"NCT04040322","sponsor":"Civi Biopharma, Inc.","briefTitle":"Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)","officialTitle":"A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-10-14","primaryCompletion":"2021-06-09","completion":"2021-06-09","firstPosted":"2019-07-31","resultsPosted":"2025-05-25","lastUpdate":"2025-05-25"},"enrollment":198,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Raynaud's Phenomenon Secondary to Systemic Sclerosis"],"interventions":[{"type":"DRUG","name":"Placebo IV infusion","otherNames":[]},{"type":"DRUG","name":"Iloprost Injection, for intravenous use","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Iloprost Injection, for intravenous use","type":"ACTIVE_COMPARATOR"}],"summary":"This is a Phase 3, multicenter, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of iloprost on the frequency of and relief from symptomatic digital ischemic episodes in subjects with systemic sclerosis.","primaryOutcome":{"measure":"Change in Frequency of Symptomatic RP Attacks","timeFrame":"From baseline (Day 10 to Day 25 of screening period) to the end ofthe efficacy follow-up (Day 8 to Day 21).","effectByArm":[{"arm":"Placebo","deltaMin":-11.47,"sd":null},{"arm":"Iloprost Injection, for Intravenous Use","deltaMin":-12.73,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.4210"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":28},"locations":{"siteCount":30,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":97},"commonTop":["Headache","Nausea","Flushing","Pain in jaw","Vomiting"]}}